ARTICLE | Product Development
Doing the right thing isn’t enough. The public needs to know
Editor’s Commentary: A nervous public needs to hear directly from pharma heads how they are tackling COVID-19
April 7, 2020 12:11 AM UTC
Updated on Apr 10, 2020 at 7:01 PM UTC
Now is not the time for the industry to be doing good behind closed doors.
The biopharma industry has broken its norms in an all-hands-on-deck campaign to arrest the coronavirus crisis. ...